Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Receivables (2016 - 2026)

Myriad Genetics has reported Change in Receivables over the past 17 years, most recently at -$2.6 million for Q4 2025.

  • Quarterly Change in Receivables rose 35.0% to -$2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.2 million through Dec 2025, down 171.26% year-over-year, with the annual reading at -$6.2 million for FY2025, 171.26% down from the prior year.
  • Change in Receivables was -$2.6 million for Q4 2025 at Myriad Genetics, up from -$19.0 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $17.5 million in Q1 2023 and troughed at -$19.0 million in Q3 2025.
  • The 5-year median for Change in Receivables is $50000.0 (2021), against an average of $1.7 million.
  • Year-over-year, Change in Receivables plummeted 1120.0% in 2022 and then skyrocketed 2600.0% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$3.0 million in 2021, then increased by 16.67% to -$2.5 million in 2022, then skyrocketed by 52.0% to -$1.2 million in 2023, then tumbled by 233.33% to -$4.0 million in 2024, then soared by 35.0% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Change in Receivables are -$2.6 million (Q4 2025), -$19.0 million (Q3 2025), and $16.2 million (Q2 2025).